In this episode, Devang Bhuva, Senior Vice President, Corporate Development and Alliance Management at Gilead speaks with Yaron Werber, M.D., Biotechnology Analyst. They share an inside look at the deal-making process from start to finish. They discuss how deals get done, trends in oncology M&A, the framework that potential acquirers use to triage and identify potential targets, and what happens on both sides of the negotiating table.
Listen to the Podcast here.
Contact
Similar Insights
